Alzheimer's Disease News and Research RSS Feed - Alzheimer's Disease News and Research Twitter

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Abnormal protein in the brain may play important role in development of Alzheimer's disease

Abnormal protein in the brain may play important role in development of Alzheimer's disease

A recently-recognized pathologic protein in the brain may play a larger role in the development of clinical Alzheimer's disease dementia than previously recognized, according to a study by researchers at Rush University Medical Center. [More]
GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer's disease. [More]
ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

The Alzheimer's Drug Discovery Foundation announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna for use as a cancer therapy) in patients with Alzheimer's disease. [More]
Study finds no evidence that exercise may lower woman’s risk of developing MS

Study finds no evidence that exercise may lower woman’s risk of developing MS

A large, new study shows no evidence that exercise may reduce a woman's risk of developing multiple sclerosis (MS). [More]
Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Tau PET is a new and promising imaging method for Alzheimer's disease. A case study from Lund University in Sweden now confirms that tau PET images correspond to a higher degree to actual changes in the brain. According to the researchers behind the study, this increases opportunities for developing effective drugs. [More]
Experimental PET tracer can diagnose concussion-related brain degeneration in living person

Experimental PET tracer can diagnose concussion-related brain degeneration in living person

An experimental positron emission tomography (PET) tracer can effectively diagnose concussion-related brain degeneration while a person is still alive, according to a proof-of-concept study conducted at the Icahn School of Medicine at Mount Sinai and published September 27 in the journal Translational Psychiatry. [More]
Exercise can increase endocannabinoid levels even under chronic sleep loss

Exercise can increase endocannabinoid levels even under chronic sleep loss

A research group at Uppsala University has investigated how levels of endocannabinoids - which target the same receptors as cannabis - are affected by short sleep duration, and whether acute exercise can modulate this effect. [More]
Experimental drug may prevent development of multiple sclerosis in mice

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology. [More]
MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

MR Solutions has received an order for a high-powered 7T, cryogen-free, preclinical PET-MRI multi-modality imaging system from the newly formed pre-clinical imaging resource at the Zilkha Neurogenetic Institute (ZNI) at the Keck School of Medicine of the University of Southern California (USC). [More]
Texas A&M research shows nicotine could help protect the aging brain

Texas A&M research shows nicotine could help protect the aging brain

Everyone knows that tobacco products are bad for your health, and even the new e-cigarettes may have harmful toxins. [More]
CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

An international team of researchers who discovered a new gene disorder that causes severe childhood epilepsy leveraged that finding to reduce seizures in two children. [More]
Researchers identify genetic switch that may be potential target for Alzheimer's disease

Researchers identify genetic switch that may be potential target for Alzheimer's disease

A team at the MRC Clinical Sciences Centre, based at Imperial College London, has found an important part of the machinery that switches on a gene known to protect against Alzheimer's Disease. [More]
Study of classical Chinese medical literature finds references similar to Alzheimer's disease

Study of classical Chinese medical literature finds references similar to Alzheimer's disease

A new study of classical Chinese medical texts identifies references to age-related memory impairment similar to modern-day Alzheimer's disease, and to several plant-based ingredients used centuries ago -- and still in use today -- to treat memory impairment. [More]
Researchers reveal presence of toxic protein aggregates in the human brain

Researchers reveal presence of toxic protein aggregates in the human brain

The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients. [More]
Women, minorities less likely to receive stroke treatment, study finds

Women, minorities less likely to receive stroke treatment, study finds

Women and minorities may be less likely to receive treatment for stroke, according to a study published in the September 14, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. [More]
Wayne State receives NIH funding to advance brain aging research

Wayne State receives NIH funding to advance brain aging research

Wayne State University has received a $3.6 million grant from the National Institute on Aging of the National Institutes of Health for a project that will advance knowledge of brain aging, its relation to cognitive performance and the role of common vascular and metabolic risk factors in shaping the trajectories of aging. [More]
Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

A drug prescribed to many patients with schizophrenia or bipolar disorder may decrease negative symptoms for people with a certain variant of the COMT gene, suggests a new study from researchers at Columbia University Medical Center. [More]
Americans believe cancer to be major health care challenge, Mayo Clinic survey reveals

Americans believe cancer to be major health care challenge, Mayo Clinic survey reveals

While Zika remains a hot topic in the news, a new survey by Mayo Clinic reveals that Americans believe the country's most significant health care challenge is cancer. [More]
Online articles about preventing Alzheimer's disease offer poor advice, research finds

Online articles about preventing Alzheimer's disease offer poor advice, research finds

New UBC research finds that many online resources for preventing Alzheimer's disease are problematic and could be steering people in the wrong direction. [More]
Memory loss symptoms not sufficient to diagnose other forms of Alzheimer's

Memory loss symptoms not sufficient to diagnose other forms of Alzheimer's

Relying on clinical symptoms of memory loss to diagnose Alzheimer's disease may miss other forms of dementia caused by Alzheimer's that don't initially affect memory, reports a new Northwestern Medicine study. [More]
Advertisement
Advertisement